Keywords: merck, kgaa, file, erbitux, eu, following, release

Merck KGaA to file Erbitux in EU following release of strong new data

Article | 09 June 2003

Print This

Bernhard Scheuble, chief executive of Germany's Merck KGaA, has said that promising new data on the cancer drug Erbitux (cetuximab), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in